We're launching 4 Translational Centres for Rare Diseases!
1️⃣ Centre for Rare Respiratory Diseases
2️⃣ LifeArc
@Kidney_Research
Centre for Rare Kidney Diseases
3️⃣ Centre for Rare Mitochondrial Diseases
4️⃣ Centre for Acceleration of Rare Disease Trials
@MDUK_News
@4Lilyfoundation
Today, we launch a £10M fund for the identification of therapeutics that can be rapidly deployed to treat
#COVID
-19. Apply for
#funding
& read more here:
📢 Breaking news! £1m awarded for cutting-edge
#MND
therapies
LifeArc,
@mndassoc
and
@MNDoddie5
have teamed up to fund
@UCL
researchers to progress the development of two pioneering
#MotorNeuronDisease
cell and gene therapy treatments.
Read more➡️
📢£4.25m
#ResearchGrant
awarded to kick start collaborative efforts to end
#MND
. LifeArc, alongside charities, patients, researchers & government research orgs, will support
#medicalrearch
at 6 UK unis to discover MND treatments.
➡️
#MNDAwarenessDay
📢 Today we launch our new £100m programme to urgently develop new
#healthcare
solutions for the more than 300,000 people living with
#bronchiectasis
and
#cysticfibrosis
in the UK – and many more worldwide 🧵
Announcing three new Gene Therapy Innovation Hubs - recipients of £18m joint funding with
@The_MRC
&
@BBSRC
to advance new genetic treatments with potential to transform care for millions of patients including those with
#RareDisease
(1/5)
Another step forward for MND research today as the
@UKMNDRI
launches!
It's amazing to be among so many inspirational people to celebrate the Institute and its plans to accelerate the search for an MND cure.
🔗Read about the Institute and our involvement:
That's a wrap on
#LATSS2024
! Seeing over 700 scientists, experts, policy makers and innovators together discussing translation and life sciences has been incredible.
Thanks to all who attended and we look forward to seeing you again next year.
Congratulations to our Translational Challenge leader, Catherine Kettleborough, on being awarded the prestigious Honorary Fellowship by the
@BritPharmSoc
.
This achievement is a testament to Catherine's impactful contributions to life science.
📢 LifeArc commits £30M to a partnership with
@UKDRI
.
The funding will be used to translate scientific discoveries into new diagnostic tests, treatments and devices to benefit people with
#dementia
, which affects around 900,000 people in the UK today. ➡️
We're proud to announce we are sponsoring five
#Research
Fellowships at the
@DaphneJacksonTr
, in honour of our dear friend, colleague and trustee, Aisling Burnand CBE, 1964-2022.
For details about the available
#Fellowship
& application process, visit:
We are so sad to hear Doddie Weir has died. It's been a huge privilege to work with
@MNDoddie5
over the past couple of years, co-funding vital research into
#motorneurondisease
. Together with the MND community we'll continue striving for a world free of
#MND
.
RIP Doddie.
We're deeply saddened to share the news that our founder Doddie Weir has died. Doddie was a force of nature, a great family man, tremendous rugby player & loved & respected by all who knew him. Our love & best wishes are with his family.
Full statement:
We're building a validated and robust portfolio of potential MND treatment targets with
@KingsCollegeLon
through our new partnership -- the MND STaR programme.
Learn more:
Alongside great talks, we have a 'Translating Science Through Art' exhibition happening all day at
#LATSS2024
. Some of the UK's top artists and scientists joined forces to create pieces that highlight rare diseases and their impact.
It's been an inspiring start to
#LATSS2024
, with talks from Stéphane Maikovsky, Patrick Chinnery, Dame Kate Bingham and Clare Terlouw and Lord James O'Shaughnessy leading us in.
We’re proud to be part of the new
#MND
Collaborative Partnership.
The £4.25m
#ResearchFunding
will seek to discover MND treatments by coordinating
#MedicalResearch
, developing better tests, data collection, and a new study.
Learn more➡️
#MNDAwarenessDay
We're pleased to welcome Professor Roger Barker as our new chair of neurodegeneration.
🔗
With vast expertise in clinical neuroscience, he'll help to drive our mission to tackle neurodegenerative conditions.🧬
We have been nominated for 'Most Significant Contribution to the MediScience Sector' at the 2024 European MediScience Awards! 🎉
The nomination is a fantastic testament to the brilliant work being done by our team.
We are so sad to hear of the passing of Rob Burrow CBE, a huge ambassador for people living with Motor Neuron Disease (MND).
We wish to thank Rob and his family for their dedication to raising awareness and funds for research in new treatments for MND. He was a true inspiration.
Our annual reception is an opportunity to thank everyone who worked with us to accelerate science for patients during the year, to reconnect with friends and forge new friendships.
Thank you to everyone who joined us this evening.
#lifearc2030
Yesterday, we hosted a workshop with
@asthmalunguk
about transforming diagnostic issues facing people with chronic lung conditions. See the artistic minutes below 🎨
Today we're at
#BTSWinter2023
(
@BTSrespiratory
) to continue talking about what more can be done.
“The future is bright and many people are working together to create new treatments for patients.”
Inspiring words from Tom Gillingwater during our
#alsmndsymp
panel discussion!
Find out about our work in
#MND
👇
#LifeArc2030
Today we are proud to launch our new
#LifeArc2030
#strategy
which outlines our commitment to spend up to £1.3 billion by 2030 to deliver new diagnostics, drugs, devices & digital solutions to transform the way diseases are prevented, identified & treated➡️
📢 Introducing the LifeArc Gene Therapy Innovation Fund!
Today we're launching a new £5m annual fund that will provide grants to academic researchers working on innovative
#GeneTherapy
technologies.
🧵 (1/3)
📢We're excited to announce a new £30m initiative,
@PACE_AMR
, to support early-stage innovation against antimicrobial resistance. Our first £10m funding call is now open to support innovators developing new antimicrobials.
Learn more➡️
LifeArc are pleased to support the STOPCOVID project at the Uni of Edinburgh with a £2m investment. 150 scientists are being re-deployed to work on a project that aims to test existing and experimental drugs to find a treatment for
#Covid
-19. Read here:
International £5m Funding Call now open: Preclinical discovery and development of repurpose drug candidate for Motor Neuron Disease (MND).🔬
🔗
Learn more at our pre-funding call workshop in early Feb 2024 - register here:
As part of our
#MND
Translational Challenge, we’re excited to announce an innovative
#Partnership
with
@precisionlifeAI
, to accelerate the discovery and development of targeted
#Treatments
for people living with the condition🤝
Read the announcement ➡️
COVID-19 represents a global emergency. We are looking to fund
#research
which aims to repurpose already available, or in late stage of development,
#therapeutics
which have a clear path to patient within the timeframe of this pandemic. Find out more:
We're looking forward to welcoming our partners this evening to
#celebrate
the launch of our
#RareDisease
Translational Challenge.🔬
To learn more about our
#RareDisease
Translational Challenge visit👉
A great way to round off the day at
#LATSS2024
– listening to
@ProfRWinston
and Lord David Willetts talk about turbocharging translational science in UK.
We’ve joined up with
@TheCrick
to launch the LifeArc-Crick Translation Fund, making £5m available for Crick scientists to progress promising innovation to attract larger scale investment and development:
Today is
#WorldBronchiectasisDay
.
We are working with
@aluk_research
to raise awareness about bronchiectasis, why it needs attention and the research opportunities available. 🫁
Find out more:
8 new fellows have been funded through our partnership with
@CrickAfricaNet
!
Alongside funding, we'll be on hand to offer expert training in translational science, and hands-on lab experience in Edinburgh and Stevenage.
Read more:
A new study, part-funded by our MND Translational Challenge and partners
@mndassoc
, has shown how a combination of grafted replacement motor neurons and optical nerve stimulation can improve muscle function.
➡️
#MNDAdvocacy
#ALS
Here it is at last - the start of the UK wide partnership to find a cure for MND! Treatments will be years not decades. Thank you
@lifearc1
for bringing this together 🙏
#MND
#ALS
We are providing £5m to support the work of
@GenomiccStudy
@GenomicsEngland
to investigate why some people are affected more severely by
#COVID19
, plus increase our understanding about the disease. Part of our wider £27m fund for solutions to
#C19
. More:
We're excited to announce our partnership with
@TheCrick
Africa Network (CAN), which will support five African research institutions and help more young African scientists build their careers in research. 🤝
To learn about this partnership, visit ➡️
Finish line moment 🏁
Kevin Sinfield completes 101 miles in 24 hours in honour of
@Rob7Burrow
and families across the country affected by motor neurone disease.
Thank you to
@SallyNugent
and the
@BBCBreakfast
team for raising awareness 🧡
#TheExtraMile
🥁We are launching a new service, Advise & Connect, to help projects focused on
#COVID19
or future viral outbreaks get access to our advice, network and potentially an award of up to £20,000.
#innovation
#AdviseAndConnect
Find out more and apply ➡️
As part of an effort to rapidly identify new treatments that can reduce the mortality rate of
#COVID
-19, LifeArc has awarded funding to 15 clinical trials into potential therapeutics. Read more:
There's been a great buzz at our
#LifeArc2030
reception this evening and we are grateful to Professor Sir John Bell
@OxfordMedSci
for setting the scene for our new strategy - read more about it here:
We're investing £10 million into
@ukfuturehealth
, Britain's largest health research programme.
OFH will provide valuable clinical and genetic data that we can utilise to support research projects across our Translational Challenges.
🔗 Read more:
Happy
#InternationalWomensDay
! Some of the remarkable women at LifeArc have shared valuable career tips➡️
Today and everyday, it's critical to
#investinwomen
and inspire future generations to build careers in life science.
#IWD24
UK Government announces outline plans for £50 million
#MotorNeuronDisease
research funding🤝
We cautiously welcome the news & are delighted the MND Partnership has received an additional £2m to
#Research
the causes of MND & search for new treatments💊
➡️
“This is fantastic news... We know that life science can be life-changing, but it stands the best chance if researchers in the UK are able to work closely with the world’s top talent, wherever they are.” - Melanie Lee, CEO
Read our full response here 👉
Thank you Dame
@Katebingham2
, managing partner at SV Health Investors, for the uplifting keynote speech this evening.
It was inspiring to hear what made the
#Vaccine
Taskforce - “the ultimate translation achievement” - work & your vision of what is possible in the future.
We're still buzzing from
#LATSS2024
. It was incredible to see so many people come together and we're blown away by all the positive feedback!
Recordings of the sessions are coming soon on YouTube...
See you again next year!
Today we temporarily close the labs across our sites to do our part in response to the
#covid
-19 pandemic. These images are a rare sight but we will be back! In the meantime, we are working remotely.
📣 We're at
#ENCALS2023
in Barcelona this week 🐝
Paul Wright & our MND
#TranslationalChallenge
team are there with the int 🇺🇳community of researchers, industry reps, and charities - all dedicated to finding a cure for
#MND
.
More about us:
LifeArc is backing 15 clinical trials of existing therapies in
#COVID
-19. These re-purposed medicine projects were selected based on their ability to start in patients immediately and the likelihood of their success.
That’s a wrap! This year’s
#UKCFC
would not have
been possible without all our speakers donating their
time, our sponsors, our team behind the scenes and
all of you for taking part.
Thanks
#TeamCF
!
The first projects to be funded through our £30 million strategic partnership with
@UKDRI
have been announced today!
Read about them and the initiative here:
RQ Biotechnology, a company we co-founded, has today signed an agreement granting
@AstraZeneca
an exclusive worldwide licence to develop, manufacture and commercialise RQ Bio’s early-stage antibodies against SARS-CoV-2.
@UniofOxford
@GeorgeFreemanMP
Today we celebrate International Day of Women and Girls in Science! 👩🔬
We're always looking for incredible women to join us. If you'd like to contribute your skills to meaningful projects that impact lives, check out our current roles:
#WomenInScience
Expressions of interest for our £5m drug repurposing call for motor neuron disease open in February. Before that, join our webinar to answer your questions and dive into the details about the funding call -
🕒 5 February, 3 to 4:30pm
📍 Online (Zoom)
Imagine a reality where every breath is a struggle. Every 5 minutes, someone will die due to a lung condition.
Read our report with
@aluk_research
to learn how we are transforming respiratory diagnostics:
A new report details how £1.1 billion was invested by the Government and charities in rare diseases.➡️
We’re proud to play a part in funding rare disease research, ultimately helping bring benefits to patients.
@NIHRresearch
@The_MRC
Following our £10m COVID-19 funding call in March, we announced that fifteen clinical trials into potential
#therapeutics
for
#COVID
ー19 are set to start, read more here:
Great to celebrate all the remarkable
#WomenInSTEM
here at LifeArc, watch Zhi Yao, our senior scientist in target validation group giving some advice to girls in school who are interested in Science here:
#February11
#WomenInScience
#WomenInSTEM
LifeArc and the
@The_MRC
create £16m fund to establish Gene Therapy Innovation Hubs. These hubs aim to accelerate potentially curative
#genetherapy
treatments towards patients. Read more here
LifeArc will sponsor two new postdoctoral fellowships at
@ClevelandClinic
, led by
@SStaufferPhD
and Andy Merritt. Fellows will conduct early-stage research that has high potential to benefit patients. More 👇
We've partnered with
@ReActAfrica_RAN
to launch a $1.5m initiative to combat antimicrobial resistance (AMR) in Zambia and Kenya.
We aim to deliver knowledge and digital tools to improve patient care and make long-term policy and practice improvements:
Thanks to
@MNDoddie5
for joining the fund established by LifeArc and
@mndassoc
.
The additional money means we can jointly support more promising research projects aimed at realising effective
#MND
#treatments
.
➡️
We are looking forward to attending the 3rd European
#Bronchiectasis
Workshop in Milan this week to learn about the latest advances in
#Research
🫁
Find out about our
#LifeArc2030
Chronic Respiratory Initiative➡️
#EBROW2023
Last night we hosted the official launch of our
#RareDiseaseTranslational
Challenge.
We'd like to say a huge thank you to those who attended the reception and thank our speakers for delivering inspiring talks throughout the evening.
#RDTC
#LifeArc2030
Dr Ian Campbell is joining LifeArc as Chief Business Officer. Ian brings a wealth of experience in the
#lifescience
industry and will be responsible for LifeArc’s business development and partnerships. Read more here:
#translationalscience
“Please rethink the way you are approaching this and just let these scientists do their work.”
Nicola Waters, who is living with Motor Neurone Disease, urges the government to free up the £50 million funding that was announced last year ⤵️
Today we celebrate
@WomensScienceDay
at LifeArc where 50% of our employees are women. We asked some of our scientists about their career paths and advice they would give to inspire the next generation of girls. Read more here:
#February11
#WomenInScience
We’ve signed a new agreement with
@Biocartis_
which will enable us to explore the development of highly innovative assays and ultimately develop new tests that benefit patients. Read more here:
#Idylla
™
#MolecularDiagnostics
Congratulations to these three recipients of a major investment in cutting-edge gene therapy in the UK. We wish you every success in accelerating academic research programmes down the path to patient benefit.
#RareDisease
#GeneTherapy
Today marks the International Day of Women and Girls in Science, we asked some of our fantastic female scientists what advice they would give to girls in school now, watch what Afrah Sattikar had to say here:
#February11
#WomenInScience
#WomenInSTEM
Congrats to Prof
@janedaviescf
on being awarded an OBE 🎉
This honour is a testament to her dedicated service to people with cystic fibrosis, and we're proud to have her on the scientific advisory board for our Chronic Respiratory Infection Translational Challenge.
We've been appointed by
@UKDRI
to provide translational expertise to help progress their exciting discoveries. We look forward to collaborating with UK DRI to benefit people living with
#dementia
and their carers.
Looking forward to working with
@lifearc1
who will provide expertise to accelerate the translation of our researchers’ discoveries into treatments, transforming the lives of those affected by
#dementia
👉
Check out BBC Look North's interview with Dr Catriona Crombie, Head of LifeArc's Rare Disease Translational Challenge – talking about the clinical trial we funded to treat neuroferritinopathy, an ultra-rare, incurable brain disease.
🎥
We are seeking applications from academics, NHS employees and companies to address the challenges of
#COVID
-19, read here for more info on the £10m
#funding
call available Deadline: 6th April